ESMO Emphasises Importance of Cancer on Global Health Agenda at WHA

Food and Healthcare Press Releases Friday May 25, 2018 08:29
LUGANO, Switzerland--25 May--PRNewswire/InfoQuest
At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda.
(Photo: https://mma.prnewswire.com/media/696385/WHA_Global_Health_Agenda.jpg )

ESMO advocated the strengthening of health systems to achieve Universal Health Coverage and to provide essential secondary healthcare services to the millions of cancer patients who die prematurely due to lack of access to appropriate treatment.

The widespread availability of secondary healthcare services to cancer patients depends on the presence of sufficient numbers of well-trained oncology professionals with sustainable access to the resources required to perform surgery, deliver radiotherapy, administer cancer treatments, provide supportive and palliative care. ESMO is active in many of these areas and able to support individual Member States' efforts.

Alexandru Eniu, ESMO Global Policy Committee Chair: "ESMO has worked with the WHO for over 15 years to improve cancer care worldwide. The platform we were given to talk about cancer illustrates how prominent the topic is becoming on the global health agenda and confirms the relevance of our continued collaboration."

ESMO President Josep Tabernero: "It was a privilege for us to be able to speak directly to the international community about the pressing global health issue that is cancer. ESMO is ready to support the WHO and Member States in strengthening the medical oncology workforce and in identifying the most cost-effective interventions and treatments that can immediately help reduce the number of cancer deaths worldwide."

Full story: https://bit.ly/2IHXdL1

ESMO is the leading professional organisation for medical oncology. With 18,000 members representing oncology professionals from 150 countries worldwide, ESMO is the society of reference for oncology education and information.

media@esmo.org
+41-91-973-19-07
Source: European Society for Medical Oncology (ESMO)

Latest Press Release

Singapore#s first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer

Lion TCR Pte. Ltd., a Singapore-based Biotech company receives approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multicentre clinical study of its product candidate (LioCyx(TM)) for treatment of relapsed liver cancer post-liver...

Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

- Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research - Expands company's foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients - Merck to...

Kaneka officially starts continuous manufacturing under GMP

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Mamoru Kadokura) have installed continuous manufacturing equipment to be applied to pharmaceutical products at Kaneka Singapore Co. (Pte.) Ltd, (Headquarters: Singapore; President: Kazuhiko...

TIENS Group opens new high-tech Experience Store in Shenzhen

TIENS Group, one of leading corporations in the Healthcare industry, unveiled a new high-tech Customer Experience Store in Shenzhen. Li Jinyuan, founder and chairman of TIENS group, announced the official opening of its first store in the world on August...

Sotera Health#s Nordion completes the sale of its medical isotopes business to BWXT

- Nordion's increased focus on gamma technologies supports Sotera Health's company-wide commitment to Safeguarding Global Health(TM) Sotera Health LLC, the world's leading, fully integrated protector of global health, today announced the closing of the...

Related Topics